Cargando…
Pulmonary Tumor Thrombotic Microangiopathy: A New Paraneoplastic Syndrome?
This report, based on data from a clinical case, proposes that pulmonary tumor thrombotic microangiopathy, an underdiagnosed cause of pulmonary hypertension and death in patients with adenocarcinoma, is a paraneoplastic syndrome (PNS). Clinicians in general must be alert to the presence or developme...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
S. Karger AG
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4881250/ https://www.ncbi.nlm.nih.gov/pubmed/27239179 http://dx.doi.org/10.1159/000446064 |
_version_ | 1782433941399011328 |
---|---|
author | Carter, Corey A. Scicinski, Jan J. Lybeck, Harry E. Oronsky, Bryan T. |
author_facet | Carter, Corey A. Scicinski, Jan J. Lybeck, Harry E. Oronsky, Bryan T. |
author_sort | Carter, Corey A. |
collection | PubMed |
description | This report, based on data from a clinical case, proposes that pulmonary tumor thrombotic microangiopathy, an underdiagnosed cause of pulmonary hypertension and death in patients with adenocarcinoma, is a paraneoplastic syndrome (PNS). Clinicians in general must be alert to the presence or development of PNS that may precede, coincide with, follow, or herald the recurrence or the primary diagnosis of malignancy since early recognition facilitates prompt diagnosis and treatment. |
format | Online Article Text |
id | pubmed-4881250 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
publisher | S. Karger AG |
record_format | MEDLINE/PubMed |
spelling | pubmed-48812502016-05-27 Pulmonary Tumor Thrombotic Microangiopathy: A New Paraneoplastic Syndrome? Carter, Corey A. Scicinski, Jan J. Lybeck, Harry E. Oronsky, Bryan T. Case Rep Oncol Published online: April, 2016 This report, based on data from a clinical case, proposes that pulmonary tumor thrombotic microangiopathy, an underdiagnosed cause of pulmonary hypertension and death in patients with adenocarcinoma, is a paraneoplastic syndrome (PNS). Clinicians in general must be alert to the presence or development of PNS that may precede, coincide with, follow, or herald the recurrence or the primary diagnosis of malignancy since early recognition facilitates prompt diagnosis and treatment. S. Karger AG 2016-04-23 /pmc/articles/PMC4881250/ /pubmed/27239179 http://dx.doi.org/10.1159/000446064 Text en Copyright © 2016 by S. Karger AG, Basel http://creativecommons.org/licenses/by-nc/4.0/ This article is licensed under the Creative Commons Attribution-NonCommercial-4.0 International License (CC BY-NC) (http://www.karger.com/Services/OpenAccessLicense). Usage and distribution for commercial purposes requires written permission. |
spellingShingle | Published online: April, 2016 Carter, Corey A. Scicinski, Jan J. Lybeck, Harry E. Oronsky, Bryan T. Pulmonary Tumor Thrombotic Microangiopathy: A New Paraneoplastic Syndrome? |
title | Pulmonary Tumor Thrombotic Microangiopathy: A New Paraneoplastic Syndrome? |
title_full | Pulmonary Tumor Thrombotic Microangiopathy: A New Paraneoplastic Syndrome? |
title_fullStr | Pulmonary Tumor Thrombotic Microangiopathy: A New Paraneoplastic Syndrome? |
title_full_unstemmed | Pulmonary Tumor Thrombotic Microangiopathy: A New Paraneoplastic Syndrome? |
title_short | Pulmonary Tumor Thrombotic Microangiopathy: A New Paraneoplastic Syndrome? |
title_sort | pulmonary tumor thrombotic microangiopathy: a new paraneoplastic syndrome? |
topic | Published online: April, 2016 |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4881250/ https://www.ncbi.nlm.nih.gov/pubmed/27239179 http://dx.doi.org/10.1159/000446064 |
work_keys_str_mv | AT cartercoreya pulmonarytumorthromboticmicroangiopathyanewparaneoplasticsyndrome AT scicinskijanj pulmonarytumorthromboticmicroangiopathyanewparaneoplasticsyndrome AT lybeckharrye pulmonarytumorthromboticmicroangiopathyanewparaneoplasticsyndrome AT oronskybryant pulmonarytumorthromboticmicroangiopathyanewparaneoplasticsyndrome |